Drawing for KYPHA

USPTO serial 97488397

KYPHA

Reviewed by CopyMark Law Group

Reg. 7114950Status 700Registered
Filing date
Status date
Registration date
Jul 18, 2023
Examiner
GOODMAN, WENDY BETH
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with KYPHA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Hillary E. Maynard

Hillary E. Maynard Polsinelli PCPO Box 140310Kansas City, MO 64114-0310United States

Goods and services

ClassDescriptionStatusFirst use
009Scientific diagnostic apparatus for detecting, measuring, and monitoring biomarkers in biological fluids; devices for monitoring immune activity and inflammation for scientific and research purposes, namely, sensing, signaling, and monitoring devices for measurementACTIVEMar 31, 2016
010Medical diagnostic apparatus for detecting, measuring, and monitoring biomarkers in biological fluids; devices for monitoring immune activity and inflammation for medical purposesACTIVEMar 31, 2016
042Consulting services for others in the field of design development, implementation, and project management of clinical trials; providing medical and scientific research information in the field of clinical trials; providing scientific study and research, namely, providing scientific review services in the field of clinical trials; custom design and development of chemical reagents and biochemical assaysACTIVEMar 15, 2015

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 7, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 7, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 7, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 7, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Dec 7, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jul 18, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jul 18, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 2, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 2, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 12, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 24, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 24, 2023DOCKASSIGNED TO EXAMINER—
Jul 22, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 8, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance